3D model of brain tumor environment could aid personalized treatment

Glioblastoma, a rare but deadly brain cancer, is wickedly sturdy. Surgeons remove tumors only to see the cancer come back ferociously. Chemotherapy and radiation therapy have limited effects. About half of patients die within 18 months. Credit: Photo by Clayton Metz for Virginia Tech. Glioblastoma, a rare but deadly brain cancer, is wickedly sturdy. Surgeons … Read more

The Worldwide Biological Wastewater Treatment Industry is Expected to Reach $19.4 Billion by 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Biological Wastewater Treatment Market Research Report by Process (Aerobic and Anaerobic), End-Use Industry, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID -19” report has been added to ResearchAndMarkets.com’s offering. The Global Biological Wastewater Treatment Market size was estimated at USD 9,281.22 million … Read more

Saint Louis University, industry partners discover treatment for rare,

ST. LOUIS — Researchers at Saint Louis University’s School of Medicine, in collaboration with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, report the first effective drug to treat a rare, genetic liver disease that previously could only be treated with a liver transplant. ST. LOUIS — Researchers at Saint Louis University’s School of Medicine, in collaboration with … Read more

Biological and Chemical Wastewater Treatment Market Forecast, Trend Analysis To 2028 |Veolia, Suez Water Technologies & Solutions, Evoqua Water Technologies LLC, Aquatech International, Xylem Inc.

New Jersey, USA,- The Global Biological and Chemical Wastewater Treatment Market research offers a thorough analysis of the market throughout the course of the projection period. The study includes a number of sections as well as an examination of the occasions and elements that are most likely to have a major impact in the future. … Read more

Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis

SALT LAKE CITY, July 21, 2022 / PRNewswire / – Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced that the European Commission has granted Recursion Orphan Drug Designation for REC-4881 for the potential treatment of familial adenomatous polyposis (FAP). REC-4881 is an orally bioavailable, non-ATP-competitive allosteric small molecule … Read more

Pediatric Obesity Treatment Options

Pediatric obesity is a serious problem, not only in the United States but worldwide. Unfortunately, the ongoing COVID-19 pandemic has worsened the epidemic of childhood obesity. Solutions for treating the millions of children and adolescents with obesity are desperately needed because prevention efforts over the past several decades have not been sufficient in slowing the … Read more

Genetic discovery to improve lung cancer treatment – BIOENGINEER.ORG

Lung cancer is the deadliest form of cancer, accounting for an estimated 1.8 million deaths worldwide. Lung cancer is the deadliest form of cancer, accounting for an estimated 1.8 million deaths worldwide. Treatment for the condition has improved in recent years – and a new Edith Cowan University study has found how to make it … Read more

Potential Risk for Methadone Treatment in Pregnancy

WASHINGTON, July 13, 2022 (GLOBE NEWSWIRE) – A recently published article in Experimental Biology and Medicine (Volume 247, Issue 12, June, 2022) identifies a potential risk to using Methadone treatment for opioid dependency in pregnancy. The study, led by Dr. Jun Cai, Department of Pediatrics, and Dr. Lori A. Devlin, Department of Pediatrics at the … Read more

Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation – BIOENGINEER.ORG

BUFFALO, NY- July 6, 2022 – Researchers from Eli Lilly and Company published a new research paper in Oncotarget on July 2, entitled, “Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation. ” Credit: Torres-Guzmán et. al. BUFFALO, NY- July 6, 2022 – Researchers from Eli Lilly and Company … Read more

A review in portal hypertension & cirrhosis provides clarity on key aspects of disease impact and treatment – BIOENGINEER.ORG

Body composition — the distribution of bone, muscle, and fat in the body — can yield vital information on the metabolic and nutritional status of a patient. Several studies have demonstrated the impact of abnormalities such as sarcopenia, which is a gradual decline in skeletal muscle mass and / or strength, and obesity, defined as … Read more